Although initially identified as an inhibitor of osteoclastogenesis (57), granulocyte macrophage-colony stimulating factor (GM-CSF), produced by breast cancer cells, has been recently found to increase the number of OCs and bone metastatic potential (58). This evidence concerns the gene CSF2 and breast carcinoma.